𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Boceprevir: A Protease Inhibitor for the Treatment of Hepatitis C

✍ Scribed by Chang, Mei H.; Gordon, Lori A.; Fung, Horatio B.

Book ID
119218639
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
666 KB
Volume
34
Category
Article
ISSN
0149-2918

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

ChemInform Abstract: Challenges in Moder
ChemInform Abstract: Challenges in Modern Drug Discovery: A Case Study of Boceprevir, an HCV Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
✍ F. George Njoroge; Kevin X. Chen; Neng-Yang Shih; John J. Piwinski πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons βš– 24 KB πŸ‘ 3 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a β€œFull Text” option. The original article is trackable v

Characterization of resistance to the pr
Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus–infected patients
✍ Simone Susser; Christoph Welsch; Yalan Wang; Markus Zettler; Francisco S. Doming πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 543 KB

Boceprevir is a hepatitis C virus (HCV) nonstructural protein (NS) 3/4A protease inhibitor that is currently being evaluated in combination with peginterferon alfa-2b and ribavirin in phase 3 studies. The clinical resistance profile of boceprevir is not characterized in detail so far. The NS3 protea